TP53 and lung adenocarcinoma: Recently, Jordi et al. [97] successfully used CRISPR-Cas9 technology to knock out the expression of p53 protein in human lung adenocarcinoma cells in vitro, and planned to add a normal copy of p53 to the same gene delivery system to correct abnormal genes.